Cold&flue

Details for Australian Patent Application No. 2009202081 (hide)

Owner Lashan, T.

Inventors Lashan, Tom

Agent Thomas Lashan

Pub. Number AU-A-2009202081

Filing date 27 May 2009

Wipo publication date 16 December 2010

International Classifications

A61K 31/223 (2006.01)

A61K 31/07 (2006.01)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/14 (2006.01) Medicinal preparations containing inorganic active ingredients - Alkali metal chlorides

A61K 33/26 (2006.01) Medicinal preparations containing inorganic active ingredients - Iron

A61K 33/32 (2006.01) Medicinal preparations containing inorganic active ingredients - Manganese

A61K 36/28 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 36/752 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

11 June 2009 Complete Application Filed

16 December 2010 Application Open to Public Inspection

  Published as AU-A-2009202081

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202082-Multicarrier transmission using a plurality of symbol lengths

2009202080-Use of dipeptidyl peptidase IV inhibitors